Alzheimer’s Talks Teleconference July 14

Tuesday, July 14, the Alzheimer's Talks Teleconference from 4-5 p.m. ET will feature Dr. Michael Rafii, director of the Memory Disorders Clinic and assistant professor of Neurosciences at the University of California, San Diego. He will discuss the NOBLE trial, a clinical study to evaluate an investigational drug for patients with mild-to-moderate Alzheimer's disease, and what it means for research.

He will discuss … a clinical study to evaluate an investigational drug for patients with mild-to-moderate Alzheimer's disease.

Dr. Rafii is also Medical Director of the National Institutes of Health-funded Alzheimer's Disease Cooperative Study and Attending Neurologist at the Shiley-Marcos Alzheimer's Disease Research Center.

Alzheimer’s Talks is a monthly teleconference series produced by USAgainstAlzheimer's to raise awareness about issues, and unite advocates with researchers or policy leaders. These informational interactive calls run much like a radio talk show, and provide caregivers, researchers, non-profit leaders, government officials, and other advocates direct access to the nation’s leading researchers in Alzheimer’s disease.

Anyone can join the free call via phone or online, or afterwards through the podcast or transcript. You can register for the call at Alzheimer’s Talks.

The Wednesday, Aug. 19, Alzheimer's Talks Teleconference will feature Dr. Scott Mackin, associate professor of Psychiatry at University of California, San Francisco School of Medicine who is principal investigator for the Alzheimer's Disease Neuroimaging Initiative Depression Project.

Editor's note: USAgainstAlzheimer’s (USA2) is committed to ending Alzheimer's by 2020. USAgainstAlzheimer's presses for greater urgency from government, industry and the scientific community in the quest for an Alzheimer's cure. The organization accomplishes this through effective leadership, collaborative advocacy and strategic investments.

USAgainstAlzheimer's and the General Board of Church & Society (GBCS) of The United Methodist Church recently announced the launch of the Faith United Against Alzheimer's Coalition (FUAAC), a cooperative effort to mobilize all elements of the faith community in the fight against Alzheimer’s disease and related dementias.

As founders of the coalition, USAgainstAlzheimer’s and GBCS will work with faith-based organizations to promote dignity, compassionate care and quality of life for individuals with Alzheimer’s disease, provide support for families, and call on industry leaders, community stakeholders and policymakers to work urgently to find disease-modifying treatments and a cure.

Letter to the Editor